These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase. Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339 [TBL] [Abstract][Full Text] [Related]
3. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies. Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics. Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794 [TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase. Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949 [TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease. Etemadi A; Hemmati S; Shahrivar-Gargari M; Abibiglue YT; Bavili A; Hamzeh-Mivehroud M; Dastmalchi S Chem Biodivers; 2023 Aug; 20(8):e202300075. PubMed ID: 37458518 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease. Osman W; Mohamed T; Sit VM; Vasefi MS; Beazely MA; Rao PP Chem Biol Drug Des; 2016 Nov; 88(5):710-723. PubMed ID: 27282589 [TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Investigation of New Diphenyl Substituted Pyridazinone Derivatives as Both Cholinesterase and Aβ-Aggregation Inhibitors. Kilic B; Erdogan M; Gulcan HO; Aksakal F; Oruklu N; Bagriacik EU; Dogruer DS Med Chem; 2019; 15(1):59-76. PubMed ID: 29792155 [TBL] [Abstract][Full Text] [Related]
10. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation. Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578 [TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase. Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700 [TBL] [Abstract][Full Text] [Related]
12. Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors. Taha M; Rahim F; Uddin N; Khan IU; Iqbal N; Anouar EH; Salahuddin M; Farooq RK; Gollapalli M; Khan KM; Zafar A Int J Biol Macromol; 2021 Oct; 188():1025-1036. PubMed ID: 34390751 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, biochemical and computational evaluations of novel bis-acylhydrazones of 2,2'-(1,1'-biphenyl)-4,4'-diylbis(oxy))di(acetohydrazide) as dual cholinesterase inhibitors. Ibrahim M; Halim SA; Latif A; Ahmad M; Ali S; Ullah S; Khalid A; Abdalla AN; Khan A; Al-Harrasi A; Ali M Bioorg Chem; 2024 Mar; 144():107144. PubMed ID: 38281382 [TBL] [Abstract][Full Text] [Related]
14. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease. El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives. Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577 [TBL] [Abstract][Full Text] [Related]
16. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study. Vafadarnejad F; Karimpour-Razkenari E; Sameem B; Saeedi M; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents. Luo W; Su YB; Hong C; Tian RG; Su LP; Wang YQ; Li Y; Yue JJ; Wang CJ Bioorg Med Chem; 2013 Dec; 21(23):7275-82. PubMed ID: 24148835 [TBL] [Abstract][Full Text] [Related]
18. N-Substituted piperidine-3-carbohydrazide-hydrazones against Alzheimer's disease: Synthesis and evaluation of cholinesterase, beta-amyloid inhibitory activity, and antioxidant capacity. Parlar S; Sayar G; Tarikogullari AH; Karadagli SS; Alan E; Sevin G; Erciyas E; Holzgrabe U; Alptuzun V Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200519. PubMed ID: 36461719 [TBL] [Abstract][Full Text] [Related]
19. [Design, synthesis and evaluation of bis-nicotine derivatives as inhibitors of cholinesterases and beta-amyloid aggregation]. Luo W; Zhao YM; Tian RG; Su YB; Hong C Yao Xue Xue Bao; 2013 Nov; 48(11):1671-6. PubMed ID: 24475704 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer's disease. Ghotbi G; Mahdavi M; Najafi Z; Moghadam FH; Hamzeh-Mivehroud M; Davaran S; Dastmalchi S Bioorg Chem; 2020 Oct; 103():104186. PubMed ID: 32890993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]